Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Factors associated with high costs of patients with metabolic dysfunction-associated steatotic liver disease: an observational study using the French CONSTANCES cohort.
Clin Diabetes Endocrinol. 2024 Apr 25;10(1):9. doi: 10.1186/s40842-023-00163-4.
Clin Diabetes Endocrinol. 2024.
PMID: 38659082
Free PMC article.
A new NRF2 activator for the treatment of human metabolic dysfunction-associated fatty liver disease.
Hammoutene A, Laouirem S, Albuquerque M, Colnot N, Brzustowski A, Valla D, Provost N, Delerive P, Paradis V; QUID-NASH Research Group.
Hammoutene A, et al. Among authors: brzustowski a.
JHEP Rep. 2023 Jul 12;5(10):100845. doi: 10.1016/j.jhepr.2023.100845. eCollection 2023 Oct.
JHEP Rep. 2023.
PMID: 37663119
Free PMC article.
Item in Clipboard
Prospective direct comparison of non-invasive liver tests in outpatients with type 2 diabetes using intention-to-diagnose analysis.
Poynard T, Deckmyn O, Peta V, Paradis V, Gautier JF, Brzustowski A, Bedossa P, Castera L, Pol S, Valla D; Quid-Nash Consortium.
Poynard T, et al. Among authors: brzustowski a.
Aliment Pharmacol Ther. 2023 Nov;58(9):888-902. doi: 10.1111/apt.17688. Epub 2023 Aug 29.
Aliment Pharmacol Ther. 2023.
PMID: 37642160
Item in Clipboard
Characterization and Pharmacological Validation of a Preclinical Model of NASH in Göttingen Minipigs.
Duvivier V, Creusot S, Broux O, Helbert A, Lesage L, Moreau K, Lesueur N, Gerard L, Lemaitre K, Provost N, Hubert EL, Baltauss T, Brzustowski A, De Preville N, Geronimi J, Adoux L, Letourneur F, Hammoutene A, Valla D, Paradis V, Delerive P.
Duvivier V, et al. Among authors: brzustowski a.
J Clin Exp Hepatol. 2022 Mar-Apr;12(2):293-305. doi: 10.1016/j.jceh.2021.09.001. Epub 2021 Sep 8.
J Clin Exp Hepatol. 2022.
PMID: 35535064
Free PMC article.
Item in Clipboard
Clinical Interest of Serum Alpha-2 Macroglobulin, Apolipoprotein A1, and Haptoglobin in Patients with Non-Alcoholic Fatty Liver Disease, with and without Type 2 Diabetes, before or during COVID-19.
Deckmyn O, Poynard T, Bedossa P, Paradis V, Peta V, Pais R, Ratziu V, Thabut D, Brzustowski A, Gautier JF, Cacoub P, Valla D.
Deckmyn O, et al. Among authors: brzustowski a.
Biomedicines. 2022 Mar 17;10(3):699. doi: 10.3390/biomedicines10030699.
Biomedicines. 2022.
PMID: 35327501
Free PMC article.
Item in Clipboard
Prospective external validation of a new non-invasive test for the diagnosis of non-alcoholic steatohepatitis in patients with type 2 diabetes.
Poynard T, Paradis V, Mullaert J, Deckmyn O, Gault N, Marcault E, Manchon P, Si Mohammed N, Parfait B, Ibberson M, Gautier JF, Boitard C, Czernichow S, Larger E, Drane F, Castille JM, Peta V, Brzustowski A, Terris B, Vallet-Pichard A, Roulot D, Laouénan C, Bedossa P, Castera L, Pol S, Valla D; Quid-Nash consortium.
Poynard T, et al. Among authors: brzustowski a.
Aliment Pharmacol Ther. 2021 Oct;54(7):952-966. doi: 10.1111/apt.16543. Epub 2021 Aug 16.
Aliment Pharmacol Ther. 2021.
PMID: 34398492
Free PMC article.
Item in Clipboard
Cite
Cite